Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Main|Search|PHGKB
Search PHGKB:

Last Posted: Dec 02, 2022
spot light Highlights

When It Comes to Breast Cancer, Sometimes It’s All in the Family
G Miller, CDC Cancer, Blog, October 2022 Brand

Has anyone ever told you that you have your mother’s eyes? Or that you look just like your grandmother? We all get our looks and physical traits from our families, but we may not always think about risks we share for diseases like cancer, including breast cancer. The good news is that knowing your family cancer history can give you a head start toward preventing breast cancer. No matter your gender, it’s important to know your risk and learn how to protect yourself.

Breast Cancer Awareness Month 2022 Digital Media Toolkit
CDC, October 5, 2022 Brand

In support of the national Breast Cancer Awareness Month October 2022 observance, the CDC Division of Cancer Prevention and Control will focus messaging and activities on finding cancer early, when it’s easiest to treat. Content and activities will be structured to empower people to take the steps needed to find breast cancer early, when it’s easiest to treat by: Knowing your risk for breast cancer; Knowing how you can lower your risk of breast cancer Knowing your family history; Knowing when to get a breast cancer screening; Knowing where to get a breast cancer screening

To prevent unnecessary biopsies, scientists train an AI model to predict breast cancer risk from MRI scans
JW Lee, Stat News, October 3, 2022

In a new paper, Witowski and his colleagues at NYU and Jagiellonian University in Poland present an artificial intelligence tool that can predict the probability of breast cancer in MRI scans as well as a panel of board-certified radiologists. In a retrospective analysis, it was also capable of reducing unnecessary biopsies by up to 20% for patients whose MRIs show suspicious lesions that might warrant a biopsy, officially known as BI-RADS category 4 lesions.

Two Factors to ID Men at Highest Risk for Prostate Cancer Death
R Nelson, Medscape, September 2022

A family history of prostate cancer has long been one of the few universally accepted risk factors for the disease. New findings now provide evidence that risk stratification based on family history and inherited polygenic risk can identify men at highest risk of dying from the disease before age 75. Men in the upper quartile of polygenic risk score or who had a family history of prostate or breast cancer accounted for close to 100% of prostate cancer deaths by age 75. This strategy can also identify men at low risk for prostate cancer, potentially sparing them from intensive prostate cancer screening.


Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.

TOP